BASF's Two-Track Strategy: Raising Prices While Reshaping the Portfolio
Published on 08/25/2026 at 15:11 | Redaktion boerse-global.de
The chemicals giant is attacking its margin problem from two directions at once. On one front, BASF is pushing through a fresh round of price increases across North America and Europe; on the other, it is laying the groundwork for a landmark structural shift — the public listing of its agricultural division, now pencilled in for the first half of 2027.
From 1 September, the Ludwigshafen-based group will raise prices for caprolactam, polyamide 6 and copolyamide by $0.08 per pound in the US and Canada, subject to existing contract terms. The move follows increases announced just days earlier in Europe for neopentyl glycol and 1,6-hexanediol, up €250 and €300 per tonne respectively. Management cites supply-demand dynamics and higher raw material costs for both sets of adjustments, which span multiple product lines and two continents — a clear signal that BASF intends to defend margins through pricing power rather than relying on volume growth alone.
Investors have had plenty to digest beyond the pricing announcements. The planned initial public offering of Agricultural Solutions is taking firmer shape, with BASF intending to retain a majority stake in the business rather than sell it outright. Analysts value the division at between €20 billion and €30 billion, and the prospect of a separate listing would allow the market to assign a standalone valuation to one of the group's more profitable segments — a point long flagged by critics who argue the unit's worth is buried within the wider conglomerate structure.
Buybacks and a Busy Pipeline
Alongside the pricing push, the company's share repurchase programme continues to grind on. Between 10 and 14 August, BASF bought back 695,000 of its own shares, bringing the cumulative total since the programme launched earlier this month to 1.24 million. The buyback underscores capital discipline and provides a modest floor under the stock, even if its daily impact is barely perceptible.
Operationally, the group is advancing on several fronts. In Mumbai, a new global performance laboratory for diapers and superabsorbents has opened, consolidating technical and application services for customers worldwide. Agricultural Solutions has unveiled the second generation of its xarvio CONNECT handheld device, designed to simplify digital field management, and has committed a mid-double-digit million-euro investment to a new Climate Center at its Limburgerhof headquarters, expanding development and registration capacity for crop protection products. The consumer care division, meanwhile, has gained US market access for its Tinosorb S sunscreen ingredient following FDA approval of the BEMT active component.
The restructuring agenda extends beyond the agribusiness spin-off. At Ludwigshafen, construction is underway on a 50-megawatt industrial heat pump that will capture waste heat from a steam cracker, targeting annual CO2 savings of up to 100,000 tonnes. Smaller international moves include a partnership with NEO Corporate for Thailand's personal care market and the North American launch of xarvio CONNECT 2.0, which links farm machinery data with the FIELD MANAGER software.
A Stock Closing in on Its Highs
The market has taken a favourable view of recent developments. After gaining 1.6 percent on Monday, the shares closed at €52.38, up 8.4 percent over the past 30 days. Year-to-date, the stock has advanced 18 percent, leaving it just 4.9 percent shy of its 52-week high of €55.05 reached in mid-April. The current price also stands roughly 25 percent above the October trough of €41.55, underscoring a steady recovery since the autumn low — a resilience that has held despite production curtailments linked to low Rhine water levels two weeks ago.
While BASF works to stabilise earnings, chemical manufacturers face another kind of risk on the shop floor — one that regulators are scrutinising more closely than ever. Handling hazardous substances without proper documentation can expose your business to costly penalties. A free COSHH toolkit provides 43 ready-to-use templates and checklists to help you meet your legal duties for assessing dangerous substances. Download the free COSHH Toolkit
Not everyone is convinced. UBS raised its price target from €52 to €55 in late July following second-quarter results, maintaining a "Neutral" rating. JPMorgan, by contrast, reiterated "Underweight" in early August — evidence that the planned corporate overhaul has yet to win over all market participants.
With the agribusiness listing still more than two years away, the near-term catalyst for the stock may hinge less on day-to-day operations and more on how quickly investors begin pricing in the potential value unlock. Each step towards the IPO — the timing window, the retained majority, the valuation range — gives the market fresh data points to reassess the conglomerate's worth. Combined with the pricing offensive and the steady cadence of buybacks, BASF is clearly working multiple levers simultaneously to stabilise earnings and reshape its future profile.
